Effective and safe use of immune checkpoint inhibitors for non‐small cell lung cancer in people living with <scp>HIV</scp>
Rebekka Mispelbaum(University Hospital Bonn), Malte B. Monin(University Hospital Bonn), Maximilian Christopeit(Universität Hamburg), Julian Philipp Layer(University Hospital Bonn), Tessa Hattenhauer(University Hospital Bonn), Winfried Alsdorf(Universität Hamburg), Clara Lehmann(University of Cologne), Julia Roider(German Center for Infection Research), Carsten Bokemeyer(Universität Hamburg), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Peter Brossart(University Hospital Bonn), Franz‐Georg Bauernfeind(University Hospital Bonn), Marcus Hentrich(Red Cross Hospital)
Cited by 3
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k